No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs370933020 |
chr5:99687647-99687648 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs559153340 |
chr5:99687739-99687740 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs532983896 |
chr5:99687822-99687823 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs551143458 |
chr5:99687840-99687841 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs569652551 |
chr5:99687957-99687958 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs397844022 |
chr5:99696414-99696415 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs77352306 |
chr5:99696427-99696428 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs577490270 |
chr5:99696436-99696437 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs377291923 |
chr5:99696462-99696463 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs369647221 |
chr5:99696463-99696464 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs181112344 |
chr5:99696464-99696465 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs550387885 |
chr5:99696467-99696468 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs186310821 |
chr5:99696473-99696474 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs549208870 |
chr5:99696474-99696475 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs562034343 |
chr5:99696506-99696507 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs529442185 |
chr5:99696510-99696511 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs547791720 |
chr5:99696537-99696538 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs566101469 |
chr5:99696560-99696561 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs116064876 |
chr5:99696570-99696571 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs568959966 |
chr5:99696571-99696572 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs551795739 |
chr5:99696594-99696595 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs562966563 |
chr5:99699808-99699809 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs151320005 |
chr5:99699851-99699852 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs188548013 |
chr5:99699888-99699889 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs140589351 |
chr5:99699889-99699890 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs112564814 |
chr5:99699901-99699902 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs181353902 |
chr5:99699927-99699928 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs2447771 |
chr5:99699931-99699932 |
Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
29 |
rs549490972 |
chr5:99699948-99699949 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs2447770 |
chr5:99699974-99699975 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs537779506 |
chr5:99699984-99699985 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs2447769 |
chr5:99700026-99700027 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs60036514 |
chr5:99700040-99700041 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs568177476 |
chr5:99700044-99700045 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs536307516 |
chr5:99700078-99700079 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs2617338 |
chr5:99700086-99700087 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs554646034 |
chr5:99700107-99700108 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs566670798 |
chr5:99700118-99700119 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs144070955 |
chr5:99700133-99700134 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs562432536 |
chr5:99700145-99700146 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs527875213 |
chr5:99700151-99700152 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs569342386 |
chr5:99700177-99700178 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs1841605 |
chr5:99700195-99700196 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs185135597 |
chr5:99700230-99700231 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs7734705 |
chr5:99700233-99700234 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
46 |
rs115986641 |
chr5:99700249-99700250 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs1841606 |
chr5:99700252-99700253 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
48 |
rs542491202 |
chr5:99700260-99700261 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs560282201 |
chr5:99700271-99700272 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs147433777 |
chr5:99700274-99700275 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|